Rimo Health Pricing: The Flat Fee, the From-Figure, and the Fees Beside It

What Rimo publishes, exactly

The from-figure lives on Rimo's marketing pages rather than its pricing page: 'Rimo's flat platform fee starts at $2,500 a month and does not rise with patient count; the plan tier you land on depends on your volume and needs,' its flat-fee explainer says, and two other pages carry the same figure. The pricing page itself shows the tier structure (Growth for first launches, Plus for brands scaling past their first thousand patients, Enterprise for custom work) with inclusions per tier and no dollar amounts. So the published state is a floor and a shape: you know the model and the entry figure; your tier's actual price arrives on the call.

The fee-model planks are stated plainly and consistently: no revenue share and no percentage-of-sales platform fee, no transaction fees, no setup fees, month to month, with patient revenue settling into your own merchant account. Two costs are explicitly beside the flat fee rather than inside it, in Rimo's own words: 'Rimo bills consultation fees and card processing separately,' with neither amount published. An expedited-filing option is a one-time fee quoted on the call. The flat fee, in other words, prices the rails; the per-patient clinical and processing costs ride on top.

A from-figure is a floor, not a price. The three numbers that complete it: your tier's actual fee, the per-consultation fee at your volume, and the card-processing terms, all in writing.

What moved in 2026, and what to ask about it

Earlier copy across this category, ours included, cited a no-medication-markup plank in Rimo's positioning. At the September 8, 2026 re-check, that language was not on Rimo's site: no markup, wholesale, or pass-through wording appears on the home, pricing, or flat-fee pages. That is not an accusation of anything; vendors tune their planks constantly. It does mean medication economics are currently unstated, and for a recurring-Rx program the per-fill picture is the margin, so ask directly: what does a fill cost through the integrated pharmacies (Rimo cites 10+ partners), how is that price evidenced, and what happens to it at volume.

Rimo's own marketing carries a worked example worth reading as exactly that, its own illustrative math: at 500 patients spending $200 a month, a 10% revenue share would cost $10,000 a month against $2,500 on Rimo's flat fee, with breakeven around 125 patients. The arithmetic is fair as far as it goes; your model should redo it with your numbers, your tier's actual fee, and the separately billed consult and processing costs included, because those are the lines the illustration leaves out.

• Your tier's actual platform fee (the published figure is a from-price), in writing
• The per-consultation fee at your projected volume, and how it changes as you grow
• Card-processing terms behind the no-transaction-fee plank
• Per-fill medication economics through the integrated pharmacies, evidenced how
• What Growth versus Plus actually gates for your program, priced against the difference

From the from-figure to your real number

Model it as three stacked lines plus the work. Line one is the platform fee at your tier. Line two is consults: your projected visit volume times the per-consultation fee you get in writing. Line three is medication: fills per patient per month times the evidenced per-fill cost. Then add the operating work the flat fee deliberately leaves with you (support, retention, compliance posture, growth), because Rimo's own footer states the division plainly: it provides the infrastructure and software, independent licensed providers make the clinical decisions, and brand operators run the non-clinical business.

Divide the whole stack by active patients at launch volume and at your twelve-month target. The flat fee's virtue is that it amortizes as you grow; the consult and medication lines are the ones that scale with you, which is why the unpublished numbers matter more than the published one. Our startup cost calculator assembles the surrounding budget, and the KPI reference holds the retention checkpoints the denominator depends on.

How EmbedCare prices the same problem

EmbedCare's answer to the same legibility instinct is a different scope: flat product rates on the whole operated stack, fixed in a signed partner agreement, with medication included on GLP-1 programs and the storefront, 50-state clinicians, owned pharmacy supply, retention, and compliance run behind your brand, with a self-serve Launch tier starting at $495/mo. A flat fee on rails and a flat rate on the operated product are both honest shapes; they buy different amounts of business. Model your all-in cost per active patient under each at the same volume and let the spreadsheet decide.